The ProVent Trial is a phase 3 trial for men on active surveillance. The trial is designed to evaluate the efficacy of Provenge for men who are still at one of the earliest stages of the disease, active surveillance. The trial’s goal is to assess the ability of Provenge to reduce the risk of disease progression in men on Active Surveillance.
Stand Up To Cancer announced an initiative that will both help scientists understand the emerging coronavirus pandemic and ensure the needs of cancer patients and survivors are being included as the research goes forward.
